The global telemedical market, which encompasses tech that facilitates remote medical diagnosis and treatment, is expected to climb from its current $38.3 billion valuation to $130.5 billion by 2025. That might sound optimistic, but consider this: As of 2018, there were already seven million telehealth users worldwide (up from an estimated 350,000 in 2013), and according to a recent survey by Becker Hospital Review, over 75% of Americans say they’re willing to attend a doctor’s appointment remotely. The sector’s strength is no doubt one reason why CirrusMD, which describes itself as a “chat-first” virtual care provider, caught investors’ attention.